This site is intended for healthcare professionals only


Prostate Cancer UK

Company profile

Prostate Cancer UK’s top priority is funding research to stop prostate cancer killing men. We’re investing millions to find better treatments and better tests that can spot fast-growing cancers early, and could be used in a screening programme to save thousands of lives.

We were the first national organisation for prostate cancer in the UK. Our aim was to improve the care and welfare of those affected by prostate cancer, increase investment in research, and raise public and political awareness of a long-neglected disease. In the last 20 years, we’ve invested over £37 million into ground breaking research, and continue to provide award-winning support for men.

We have grown in size, strength and influence but our ambition is the same: to put men at the heart of everything we do.


Prostate Cancer Specialist course

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

Resources for Health Professionals- Risk Campaign

Prostate Cancer Risk Management Programme and Prostate Cancer UK’s Consensus Statements on PSA testing

Chronic prostatitis and chronic pelvic pain syndrome: a consensus guideline

This quick reference guide contains priorities for implementation and a treatment algorithm.

PSA Consensus Statements

Our PSA consensus statements represent the consensus view of hundreds of health professionals, to support primary health care professionals to use the PSA test more effectively for men without symptoms of prostate cancer.

PCRMP & Prostate Cancer UK Consensus statements

Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.

© Copyright Omniamed Communications. All Rights Reserved 108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom